NCT03377244 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Clark MM, Abrams DB, Niaura RS, Eaton CA, Rossi JS
Self-efficacy in weight management. J Consult Clin Psychol. 1991 Oct;59(5):739-44.
Gruber KJ
Social support for exercise and dietary habits among college students. Adolescence. 2008 Fall;43(171):557-75.
Resnick B, Jenkins LS
Testing the reliability and validity of the Self-Efficacy for Exercise scale. Nurs Res. 2000 May-Jun;49(3):154-9.
Resnick B, Luisi D, Vogel A, Junaleepa P
Reliability and validity of the self-efficacy for exercise and outcome expectations for exercise scales with minority older adults. J Nurs Meas. 2004 Winter;12(3):235-47.
Shannon J, Kristal AR, Curry SJ, Beresford SA
Application of a behavioral approach to measuring dietary change: the fat- and fiber-related diet behavior questionnaire. Cancer Epidemiol Biomarkers Prev. 1997 May;6(5):355-61.

Healthy Body Healthy Souls: A Weight Loss Intervention Using Diabetes Prevention Program Lifestyle Intervention (DPP-LI) With Church Level Systems Change in the Marshallese Population

Details for clinical trial NCT03377244

Clinical trial NCT03377244 - References